Doranz B J, Lu Z H, Rucker J, Zhang T Y, Sharron M, Cen Y H, Wang Z X, Guo H H, Du J G, Accavitti M A, Doms R W, Peiper S C
Department of Pathology, University of Pennsylvania, Philadelphia 19104, USA.
J Virol. 1997 Sep;71(9):6305-14. doi: 10.1128/JVI.71.9.6305-6314.1997.
The chemokine receptor CCR5 is the major fusion coreceptor for macrophage-tropic strains of human immunodeficiency virus type 1 (HIV-1). To define the structures of CCR5 that can support envelope (Env)-mediated membrane fusion, we analyzed the activity of homologs, chimeras, and mutants of human CCR5 in a sensitive gene reporter cell-cell fusion assay. Simian, but not murine, homologs of CCR5 were fully active as HIV-1 fusion coreceptors. Chimeras between CCR5 and divergent chemokine receptors demonstrated the existence of two distinct regions of CCR5 that could be utilized for Env-mediated fusion, the amino-terminal domain and the extracellular loops. Dual-tropic Env proteins were particularly sensitive to alterations in the CCR5 amino-terminal domain, suggesting that this domain may play a pivotal role in the evolution of coreceptor usage in vivo. We identified individual residues in both functional regions, Asp-11, Lys-197, and Asp-276, that contribute to coreceptor function. Deletion of a highly conserved cytoplasmic motif rendered CCR5 incapable of signaling but did not abrogate its ability to function as a coreceptor, implying the independence of fusion and G-protein-mediated chemokine receptor signaling. Finally, we developed a novel monoclonal antibody to CCR5 to assist in future studies of CCR5 expression.
趋化因子受体CCR5是1型人类免疫缺陷病毒(HIV-1)嗜巨噬细胞株的主要融合共受体。为了确定能够支持包膜(Env)介导的膜融合的CCR5结构,我们在一种灵敏的基因报告细胞-细胞融合试验中分析了人CCR5的同源物、嵌合体和突变体的活性。CCR5的猴源同源物而非鼠源同源物作为HIV-1融合共受体具有完全活性。CCR5与不同趋化因子受体之间的嵌合体表明,CCR5存在两个可用于Env介导融合的不同区域,即氨基末端结构域和细胞外环。双嗜性Env蛋白对CCR5氨基末端结构域的改变特别敏感,这表明该结构域可能在体内共受体使用的进化中起关键作用。我们在两个功能区域中鉴定出了对共受体功能有贡献的单个残基,即天冬氨酸-11、赖氨酸-197和天冬氨酸-276。缺失一个高度保守的胞质基序使CCR5失去信号传导能力,但并未消除其作为共受体的功能,这意味着融合与G蛋白介导的趋化因子受体信号传导相互独立。最后,我们开发了一种针对CCR5的新型单克隆抗体,以协助未来对CCR5表达的研究。